Milestone Scientific Inc. (MLSS) Stock
MLSS Key Statistics
About Milestone Scientific Inc.
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
CEO: Eric C. Hines. Company website
MLSS — Frequently Asked Questions
What is the MLSS stock price today?
Milestone Scientific Inc. (MLSS) trades at $0.27, down 7.19% on the day, as of Sep 20, 2026 14:58 UTC.
What is Milestone Scientific Inc.'s market cap?
Milestone Scientific Inc. has a market capitalisation of $21.80M, calculated from the live MLSS share price and shares outstanding.
What is the P/E ratio of MLSS?
MLSS has no meaningful price-to-earnings ratio: Milestone Scientific Inc. lost $0.07 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Milestone Scientific Inc. make?
Milestone Scientific Inc. generated revenue of $8.97M over the trailing twelve months, which puts the stock at 2.43 times sales.
What is the 52-week range for MLSS?
MLSS has traded between $0.25 and $0.33 over the past 52 weeks, and the last price is 17.6% below that high.
Is Milestone Scientific Inc. profitable?
No. Milestone Scientific Inc. is loss-making, with a net margin of -63.76% over the trailing twelve months.
What is the analyst price target for MLSS?
Wall Street analysts rate MLSS Buy, with an average price target of $4.00, 1,376.0% above the current price.
What sector is Milestone Scientific Inc. in?
Milestone Scientific Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US .
Who is the CEO of Milestone Scientific Inc.?
Eric C. Hines is the chief executive of Milestone Scientific Inc., which employs 17 people.
Where can I track MLSS in real time?
QFI Terminal shows MLSS with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See MLSS live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open MLSS in Terminal See plans